Oryzon Genomics SA (ORY) — Long-term Investment Intensity
Oryzon Genomics SA (ORY) has a Long-term Investment Intensity of 0.1% as of December 2019. Long-term investments of €40.80K represent 0.1% of total assets of €80.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Oryzon Genomics SA to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oryzon Genomics SA Long-term Investment Intensity (2013–2019)
This chart shows how Oryzon Genomics SA's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.1%, reflecting long-term investments of €40.80K against total assets of €80.09 Million EUR. Explore ORY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Oryzon Genomics SA (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Oryzon Genomics SA from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ORY market cap.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.1% | €40.80K | €80.09 Million | ▼ 0.0 pp |
| 2018 | 0.1% | €40.80K | €67.45 Million | ▼ 0.0 pp |
| 2017 | 0.1% | €41.00K | €61.04 Million | ▼ 0.0 pp |
| 2016 | 0.1% | €41.00K | €49.74 Million | ▼ -0.8 pp |
| 2015 | 0.8% | €344.29K | €40.73 Million | ▼ -1.1 pp |
| 2014 | 1.9% | €505.57K | €26.06 Million | ▼ -1.0 pp |
| 2013 | 2.9% | €844.78K | €28.76 Million | — |